Literature DB >> 27289046

Identification of Mycobacterium tuberculosis enzyme involved in vitamin D and 7-dehydrocholesterol metabolism.

A V Vasilevskaya1, A V Yantsevich1, G V Sergeev1, A P Lemish2, S A Usanov1, A A Gilep3.   

Abstract

Problems arising during treatment of tuberculosis are well known, therefore studies of Mycobacterium drug molecular targets are an area of particular importance. Members of the cytochrome P450 family (CYP) may belong to potential candidates for drug targets being involved in metabolism of biologically important molecules in the host organism. CYP124 of Mycobacterium tuberculosis (MTCYP124) catalyzes ω-hydroxylation of methyl-branched lipids. The data obtained in the present study indicate that this enzyme can also oxidize provitamin D3 (7-dehydrocholesterol) and vitamin D3. We found that the final product is different from 1α- and 25-hydroxyvitamin D3, so we propose that MTCYP124 is involved in alternative pathway for metabolism of vitamin D3.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  7-Dehydrocholesterol; Cytochrome P450; Steroid metabolism; Vitamin D

Mesh:

Substances:

Year:  2016        PMID: 27289046     DOI: 10.1016/j.jsbmb.2016.05.021

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  6 in total

Review 1.  Potential drug targets in the Mycobacterium tuberculosis cytochrome P450 system.

Authors:  Paul R Ortiz de Montellano
Journal:  J Inorg Biochem       Date:  2018-01-12       Impact factor: 4.155

2.  Whole genome sequencing analysis of a dexamethasone-degrading Burkholderia strain CQ001.

Authors:  Dan Si; Yuxia Xiong; Zhibang Yang; Jin Zhang; Lianju Ma; Jinyang Li; Yi Wang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

3.  The Potential Role of Vitamin D in the Development of Tuberculosis in Chinese Han Population: One Case-Control Study.

Authors:  Li Cai; Shuangyi Hou; Yadong Huang; Shuang Liu; Xibao Huang; Xiaoxv Yin; Nan Jiang; Yeqing Tong
Journal:  Front Med (Lausanne)       Date:  2022-07-25

Review 4.  Long-Duration Space Travel Support Must Consider Wider Influences to Conserve Microbiota Composition and Function.

Authors:  Kait F Al; John A Chmiel; Gerrit A Stuivenberg; Gregor Reid; Jeremy P Burton
Journal:  Life (Basel)       Date:  2022-07-30

5.  Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450.

Authors:  Sergey Bukhdruker; Tatsiana Varaksa; Irina Grabovec; Egor Marin; Polina Shabunya; Maria Kadukova; Sergei Grudinin; Anton Kavaleuski; Anastasiia Gusach; Andrei Gilep; Valentin Borshchevskiy; Natallia Strushkevich
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923

6.  Potency boost of a Mycobacterium tuberculosis dihydrofolate reductase inhibitor by multienzyme F420H2-dependent reduction.

Authors:  Wassihun Wedajo Aragaw; Brendon M Lee; Xuan Yang; Matthew D Zimmerman; Martin Gengenbacher; Véronique Dartois; Wai-Keung Chui; Colin J Jackson; Thomas Dick
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-22       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.